Hypersensitivity Reaction in the US Food and Drug Administration-Approved Second-Generation Drug-Eluting Stents: Histopathological Assessment With Ex Vivo Optical Coherence Tomography
Open Access
- 20 January 2015
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 131 (3), 322-324
- https://doi.org/10.1161/circulationaha.114.012658
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Zotarolimus-eluting stent-induced hypersensitivity pneumonitisThe Korean Journal of Internal Medicine, 2013
- Optical Coherence Tomography Findings in Lesions After Sirolimus-Eluting Stent Implantation With Peri-Stent Contrast StainingCirculation: Cardiovascular Interventions, 2012
- Sirolimus - Challenging Current PerspectivesTherapeutic Drug Monitoring, 2006
- Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting StentCirculation, 2004